Non-alcoholic fatty liver disease - the most common chronic liver disease - encompasses a histological spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). Over the next decade, NASH is projected to be the most common indication for liver transplantation. The absence of an effective pharmacological therapy for NASH is a major incentive for research into novel therapeutic approaches for this condition. The current focus areas for research include the modulation of nuclear transcription factors; agents that target lipotoxicity and oxidative stress; and the modulation of cellular energy homeostasis, metabolism and the inflammatory response. Strategies to enhance resolution of inflammation and fibrosis also show promise to reverse the advanced stages of liver disease.

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

MUSSO, Giovanni;CASSADER, Maurizio;GAMBINO, Roberto
Last
2016-01-01

Abstract

Non-alcoholic fatty liver disease - the most common chronic liver disease - encompasses a histological spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). Over the next decade, NASH is projected to be the most common indication for liver transplantation. The absence of an effective pharmacological therapy for NASH is a major incentive for research into novel therapeutic approaches for this condition. The current focus areas for research include the modulation of nuclear transcription factors; agents that target lipotoxicity and oxidative stress; and the modulation of cellular energy homeostasis, metabolism and the inflammatory response. Strategies to enhance resolution of inflammation and fibrosis also show promise to reverse the advanced stages of liver disease.
2016
15
249
274
Musso, Giovanni; Cassader, Maurizio; Gambino, Roberto
File in questo prodotto:
File Dimensione Formato  
Nat Rev Drug Discov_2016.pdf

Open Access dal 06/01/2017

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 1.65 MB
Formato Adobe PDF
1.65 MB Adobe PDF Visualizza/Apri
Non-alcoholic steatohepatitis_emerging molecular targets and therapeutic strategies.pdf

Accesso riservato

Descrizione: PDF editoriale
Tipo di file: PDF EDITORIALE
Dimensione 995.42 kB
Formato Adobe PDF
995.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1561598
Citazioni
  • ???jsp.display-item.citation.pmc??? 140
  • Scopus 293
  • ???jsp.display-item.citation.isi??? 280
social impact